Company Filing History:
2 out of 5,450 
1 out of 1,245 
1 out of 850 
Years Active: 2008-2009
Title: Innovations and Contributions of Inventor Kenneth R. Hess
Introduction: Kenneth R. Hess, based in Houston, Texas, is a prominent inventor with a focus on significant advancements in medical diagnostics and therapies. With a strong track record reflected in his two patents, Hess has made notable contributions to the fields of oncology and gene classification.
Latest Patents: Kenneth R. Hess's latest inventions include groundbreaking patents that have the potential to transform breast cancer detection and glioma classification. One of his notable patents, titled "Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer," provides compositions and kits aimed at detecting, characterizing, preventing, and treating human breast cancers. This invention introduces a variety of newly identified markers, which correlate changes in expression levels with the presence of breast cancer.
His second patent, "Gene sets for glioma classification," presents a series of gene markers whose expression varies in different types of gliomas. This patent allows for accurate classification of gliomas into categories such as glioblastoma multiforme (GBM), anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO), or oligodendroglioma (OL). Diagnoses can be performed on nucleic acids using methods like DNA microarrays or through immunologic means, thereby facilitating targeted therapies.
Career Highlights: Throughout his career, Kenneth R. Hess has been associated with prestigious institutions, including the Massachusetts Institute of Technology and the Texas A&M University System. His experience in these environments has allowed him to advance his research and collaborations, further enhancing his contributions to innovation in medical science.
Collaborations: Hess has collaborated with notable colleagues such as Wei Zhang and Greg Fuller, contributing to a rich exchange of ideas and fostering advancements in his areas of expertise. These collaborations have played a crucial role in the successful development of his innovative patents.
Conclusion: Kenneth R. Hess stands out as a key figure in the realm of medical innovation. His patents reflect a commitment to improving cancer diagnostics and treatments, showcasing how targeted research can lead to substantial advancements in healthcare. His work reflects the importance of collaboration and dedication to pushing the boundaries of medical science.